Literature DB >> 18993012

Risk factors for the acquisition of carbapenem-resistant Escherichia coli among hospitalized patients.

Min-Hyok Jeon1, Sang-Ho Choi, Yee Gyung Kwak, Jin-Won Chung, Sang-Oh Lee, Jin-Yong Jeong, Jun Hee Woo, Yang Soo Kim.   

Abstract

Carbapenem resistance among Gram-negative bacilli has become an increasingly serious problem worldwide, and the emergence and spread of carbapenem-resistant Escherichia coli (CREC) is also becoming a serious problem. To date, however, risk factors for CREC acquisition have not been determined, so we decided to evaluate this in hospitalized patients through matched case-control study. Nosocomially acquired CREC was isolated from 46 patients between January 1997 and December 2007. For each patient, 3 matched-control subjects were selected. Previous use of carbapenem (adjusted odds ratio [AOR], 6.50) and metronidazole (AOR, 4.25), the presence of biliary drainage catheter (AOR, 4.59), and prior hospital stay (AOR 1.02) were found as independent risk factors for CREC. Our results suggest that the nosocomial acquisition of CREC may be favored by the selection pressure of carbapenems and metronidazole and also related to prior hospital stay and the presence of biliary drainage catheter.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18993012     DOI: 10.1016/j.diagmicrobio.2008.08.014

Source DB:  PubMed          Journal:  Diagn Microbiol Infect Dis        ISSN: 0732-8893            Impact factor:   2.803


  16 in total

1.  Differential characteristics of healthcare-associated compared to community-acquired febrile urinary tract infections in males.

Authors:  A Smithson; J Ramos; M T Bastida; S Bernal; N Jove; E Niño; N Msabri; R Porrón
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2015-09-25       Impact factor: 3.267

2.  Multi-drug-resistant gram-negative bacterial infection in surgical patients hospitalized in the ICU: a cohort study.

Authors:  V G Alexiou; A Michalopoulos; G C Makris; G Peppas; G Samonis; M E Falagas
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2011-07-28       Impact factor: 3.267

Review 3.  The spread of carbapenemase-producing bacteria in Africa: a systematic review.

Authors:  Rendani I Manenzhe; Heather J Zar; Mark P Nicol; Mamadou Kaba
Journal:  J Antimicrob Chemother       Date:  2014-09-26       Impact factor: 5.790

4.  A Systematic Review and Meta-analyses of the Clinical Epidemiology of Carbapenem-Resistant Enterobacteriaceae.

Authors:  Karlijn van Loon; Anne F Voor In 't Holt; Margreet C Vos
Journal:  Antimicrob Agents Chemother       Date:  2017-12-21       Impact factor: 5.191

5.  Risk factors and mortality in the Carbapenem-resistant Klebsiella pneumoniae infection: case control study.

Authors:  Fethiye Akgul; Ilkay Bozkurt; Mustafa Sunbul; Saban Esen; Hakan Leblebicioglu
Journal:  Pathog Glob Health       Date:  2016-12-01       Impact factor: 2.894

Review 6.  Carbapenemases in Klebsiella pneumoniae and other Enterobacteriaceae: an evolving crisis of global dimensions.

Authors:  L S Tzouvelekis; A Markogiannakis; M Psichogiou; P T Tassios; G L Daikos
Journal:  Clin Microbiol Rev       Date:  2012-10       Impact factor: 26.132

7.  Risk factors, molecular epidemiology and outcomes of ertapenem-resistant, carbapenem-susceptible Enterobacteriaceae: a case-case-control study.

Authors:  Jocelyn Teo; Yiying Cai; Sarah Tang; Winnie Lee; Thean Yen Tan; Thuan Tong Tan; Andrea Lay-Hoon Kwa
Journal:  PLoS One       Date:  2012-03-26       Impact factor: 3.240

8.  Deaths attributable to carbapenem-resistant Enterobacteriaceae infections.

Authors:  Matthew E Falagas; Giannoula S Tansarli; Drosos E Karageorgopoulos; Konstantinos Z Vardakas
Journal:  Emerg Infect Dis       Date:  2014-07       Impact factor: 6.883

9.  Extended Spectrum-β-Lactamase or Carbapenemase Producing Bacteria Isolated from Patients with Acute Cholangitis.

Authors:  Ja Chung Goo; Mun Hyuk Seong; Young Kwang Shim; Hee Seung Lee; Joung-Ho Han; Jung-Ho Han; Kyeong Seob Shin; Jae-Woon Choi; Sei Jin Youn; Seon Mee Park
Journal:  Clin Endosc       Date:  2012-06-30

10.  Impact of empirical treatment in extended-spectrum beta-lactamase-producing Escherichia coli and Klebsiella spp. bacteremia. A multicentric cohort study.

Authors:  Galo Peralta; María Lamelo; Patricia Alvarez-García; María Velasco; Alberto Delgado; Juan Pablo Horcajada; María Montero; María Pía Roiz; Maria Carmen Fariñas; Juan Alonso; Luis Martínez Martínez; Alfonso Gutiérrez-Macías; Jose Angel Alava; Azucena Rodríguez; Ana Fleites; Vicente Navarro; Elia Sirvent; Jose Antonio Capdevila
Journal:  BMC Infect Dis       Date:  2012-10-05       Impact factor: 3.090

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.